Erasca Inc.

Last updated September 27, 2026

Organization details

Legal name
Erasca Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
ERAS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001761918

Board of directors

Chief executives

Jonathan E. Lim · Chairman & CEO
Dates unknown

Board connections

3 of this board's directors also sit on 4 other boards.

Network of Erasca Inc.'s board connections Biomea Fusion Inc. Biomea Fusion Inc. Boundless Bio Inc. Boundless Bio Inc. BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology The... Ernexa Therapeutics Inc. Ernexa Therapeutics In... Bihua Chen Bihua Chen James Arthur Bristol James Arthur Bristol Jonathan E. Lim Jonathan E. Lim Erasca Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
May 21, 2024 Alexander W. Casdin Director Open-market purchase +80,000 $2.27 $181,600
Dec 15, 2023 Chacko David M. Officer (CFO and CBO) Other +7,478 $1.59 $11,890
Dec 15, 2023 Garner Ebun Officer (General Counsel & Corp. Sec.) Other +5,448 $1.59 $8,662
Dec 6, 2023 Valerie Denise Harding Start Director Open-market purchase +10,000 $1.85 $18,500
Dec 6, 2023 Jonathan E. Lim Director, Officer (Chairman & CEO), 10% owner Open-market purchase +278,150 $1.72 $478,418
Dec 5, 2023 Jonathan E. Lim Director, Officer (Chairman & CEO), 10% owner Open-market purchase +721,850 $1.69 $1,219,927
Dec 4, 2023 Alexander W. Casdin Director Open-market purchase +30,000 $1.66 $49,800
Oct 5, 2023 Jonathan E. Lim Director, Officer (Chairman & CEO), 10% owner Open-market purchase +1,000,000 $2.03 $2,030,000
Jun 8, 2023 Jonathan E. Lim Director, Officer (Chairman & CEO), 10% owner Open-market purchase +100,000 $2.75 $275,000
Apr 10, 2023 Alexander W. Casdin Director Open-market purchase +20,000 $2.76 $55,200
Mar 28, 2023 Jonathan E. Lim Director, Officer (Chairman & CEO), 10% owner Open-market purchase +100,000 $2.84 $284,000
Feb 1, 2023 Chacko David M. Officer (Chief Financial Officer) Other +1,748 $4.10 $7,167
Feb 1, 2023 Wei Lin Officer (Chief Medical Officer) Other +1,748 $4.10 $7,167
Feb 1, 2023 Garner Ebun Officer (General Counsel & Corp. Sec.) Other +2,388 $4.10 $9,791
Feb 1, 2023 Chacko David M. Officer (Chief Financial Officer) Other +2 $3.89 $8

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.